Patent · US Active

Anti-variant Fc-region antibodies and method of use

US10899845B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Frank Kowalewsky · Munich, DE
Mirko Ritter · Bernried, DE
Kay-Gunnar Stubenrauch · Frauenfeld, CH
Uwe Wessels · Penzberg, DE

Key dates

Filing date	Apr 25, 2018
Grant date	Jan 26, 2021
Priority date	—
Expiry date	Apr 24, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention provides anti-variant Fc-region antibodies which specifically bind to an antibody that has the mutation P329G or the mutations P329G/L234A/L235A or the mutations I253A/H310A/H435A in the Fc-region, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.